Universal Health Services (UHS)
(Delayed Data from NYSE)
$233.14 USD
+3.85 (1.68%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $233.11 -0.03 (-0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value A Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$233.14 USD
+3.85 (1.68%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $233.11 -0.03 (-0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value A Growth D Momentum A VGM
Zacks News
What's in Store for Universal Health's (UHS) Q2 Earnings?
by Zacks Equity Research
Universal Health's (UHS) Q2 is likely to benefit from strong performances at its Acute Care and Behavioral Health segments.
Universal Health Services (UHS) Down 4.5% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Community Health (CYH) Posts Earnings in Q1, Revenues Top
by Zacks Equity Research
Community Health's (CYH) Q1reflects expansion in transfer and access program, launch of Accountable Care Organizations, and investments in outpatient capabilities and service line. However, admissions declined.
Healthcare Stock Q1 Earnings Due on Apr 25: ANTM, UHS, PRAH
by Zacks Equity Research
Severe flu activity in the first quarter should benefit companies in the health care space, while insurers might feel the pinch from the same.
Can Universal Health (UHS) Q1 Earnings Beat on Admissions?
by Zacks Equity Research
Universal Health's (UHS) first-quarter results are likely to outperform on the back of a solid segmental performance supported by rise in admissions, licensed beds as well as patient days.
Ensign Group Boosts Arizona Base With Real Estate Buyout
by Zacks Equity Research
Ensign Group's (ENSG) inclination toward inorganic growth leads to numerous acquisitions, significantly favoring the company's top line.
Universal Health (UHS) Up 2.1% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Universal Health (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Universal Health Services (UHS) a Great Stock for Value Investors Right Now?
by Zacks Equity Research
Universal Health Services (UHS) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Why did Community Health Stock Sink More Than 50% in a Year?
by Zacks Equity Research
Community Health (CYH) underperforms the industry due to rising expenses, ailing revenues and a weak guidance.
5 Growth Stocks in MedTech Set to Scale Higher in 2018
by Zacks Equity Research
The U.S. MedTech markets have been riding high with merger and acquisitions in focus.
Zacks.com featured highlights include: Louisiana-Pacific, ManpowerGroup, Kulicke and Soffa, Universal Health and DMC
by Zacks Equity Research
Zacks.com featured highlights include: Louisiana-Pacific, ManpowerGroup, Kulicke and Soffa, Universal Health and DMC
Tenet Healthcare Sells MacNeal Hospital to Streamline Trade
by Zacks Equity Research
Tenet Healthcare's (THC) divestitures aim at debt repayment, reduction of interest burden and streamlining of core business.
5 Low-Leverage Stocks to Buy as Fed Targets 4 Rate Hikes in 2018
by Zacks Equity Research
With the Federal Reserve targeting four interest rates hikes this year, the market scenario does not seem to be much in favor of companies opting for debt financing.
Why Earnings Season Could Be Great for Universal Health (UHS)
by Zacks Equity Research
Universal Health (UHS) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Can Segmental Strength Drive Integra's (IART) Q4 Earnings?
by Zacks Equity Research
Integra LifeSciences (IART) well poised to gain from strength in Orthopedics and Tissue Technologies in Q4.
Will Lower Volume Hurt Tenet Healthcare's (THC) Q4 Earnings?
by Zacks Equity Research
Industry-wide softness in admissions might affect Tenet Healthcare's (THC) fourth-quarter results.
Can PBM Unit Drive Express Scripts' (ESRX) Earnings in Q4?
by Zacks Equity Research
Express Scripts (ESRX) expects Q4 results to show earnings growth on strength in PBM segment.
HCA Healthcare's Top Line Grows on Buyouts, Bad Debts Hurt
by Zacks Equity Research
Although HCA Healthcare's (HCA) top line continues to grow on the back of admissions, industry wide softness in volume, political uncertainty and high bad debt bother.
Can Tenet Healthcare (THC) Get Back on Growth Path in 2018?
by Zacks Equity Research
Shares of Tenet Healthcare (THC) have lost significantly last year owing to lower revenues, weak margins, high bad debts and expenses.
Will Community Health Bounce Back in 2018 After a Dismal 2017?
by Zacks Equity Research
Community Health (CYH) suffered in 2017 from weak volumes and high costs. Let's see how this year unfolds.
Acadia Healthcare: 2017 Was No Good, Will 2018 be Better?
by Zacks Equity Research
Acadia Healthcare (ACHC) suffers due to weak U.K. business. Let's see how this year unfolds
Universal Health Grows Inorganically, Rising Costs a Drag
by Zacks Equity Research
Universal Health's (UHS) top line grows on solid Acute Care and Behavioral Health platforms. Nevertheless, surging level of debt bothers.
Universal Health Services (UHS) Hits 52-Week Low on Dull Q3
by Zacks Equity Research
Universal Health (UHS) stock suffers on soft third-quarter results and a tepid outlook.
Lower Admissions to Hurt Tenet Healthcare (THC) Q3 Earnings?
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings are likely to be affected by lower revenues and higher expenses
Can Admissions Rise Fuel Universal Health (UHS) Q3 Earnings?
by Zacks Equity Research
Universal Health's (UHS) third-quarter results are likely to be driven by solid revenue growth in both its Acute Care and Behavioral Health segments.